Study of a long-acting injectable in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests a new long-acting injectable medication (S-892216 LAI) in healthy adults. It helps researchers understand how the drug works in the body when given as a shot, which could lead to a treatment given less often in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a generally healthy adult volunteer.
- Your body mass index (BMI) must be between 18.5 and 32.0.
- You cannot have any major health conditions like heart disease, lung disease, liver or kidney problems, or diabetes.
- You cannot have had cancer (except for certain skin cancers removed more than 3 years ago).
- You cannot be taking any prescription or over-the-counter medications or require other treatments.
- You cannot have used cannabis, tobacco, or nicotine products in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
This study tests a new injected medicine called SYH2092 in healthy adults. It aims to see how safe it is and how the body handles it, which could help develop a future treatment for conditions like diabetes or obesity.
This study tests a new medicine called LAE102 in two groups: healthy volunteers and people who are overweight or obese. The goal is to see if it is safe and how the body processes it.
This study checks if a new injectable medication (RAY1225) behaves the same in the body as the original version. It is for healthy adults and will compare the two forms to make sure they are alike.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.